Clinical Trials Browser

Phase 2 × Has results × Androgen Antagonists × Clear all

NCT03419234 2026-03-12

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Phase 2 Active not recruiting

223 enrolled 14 charts

Prostatic Neoplasms

NCT03649841 2023-10-26

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Terminated

10 enrolled 7 charts

Prostatic Neoplasms

NCT03827473 2020-06-25

ACADEMIC

Phase 2 Terminated

1 enrolled 6 charts

Prostatic Neoplasms

NCT00283803 2018-08-07

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Phase 2 Completed

32 enrolled 9 charts

Prostatic Neoplasms

NCT00776594 2016-10-21

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Phase 2 Completed

102 enrolled 9 charts

Prostatic Neoplasms